| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Peoplesway.com Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.80% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| PLWY | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 4.1% | 1.2% |
| 1Y | n/a | -26.0% | 24.9% |
Return vs Industry: Insufficient data to determine how PLWY performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how PLWY performed against the US Market.
Price Volatility
| PLWY volatility | |
|---|---|
| PLWY Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PLWY has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PLWY's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | n/a | n/a | www.peoplesway.com |
Peoplesway.com Inc. develops and sells wellness products. It offers weight management, pain relief, skincare, and bio-identical hormone replacement products, as well as supplements. The company provides Pro-HM, a solution for hormonal imbalances in women; Pro-MC, a hormonal product for men; ProTec, an antioxidant supplement for protection against free radicals that destroy cells; and ProTrim, a dietary supplement.
Peoplesway.com Inc. Fundamentals Summary
| PLWY fundamental statistics | |
|---|---|
| Market cap | US$305.00 |
| Earnings (TTM) | US$24.49k |
| Revenue (TTM) | US$859.82k |
0.0x
P/E Ratio0.0x
P/S RatioIs PLWY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PLWY income statement (TTM) | |
|---|---|
| Revenue | US$859.82k |
| Cost of Revenue | US$428.00k |
| Gross Profit | US$431.82k |
| Other Expenses | US$407.33k |
| Earnings | US$24.49k |
Last Reported Earnings
Dec 31, 2003
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PLWY perform over the long term?
See historical performance and comparison